Brief: Aequus says initiates second proof of concept clinical trial of transdermal aripiprazole patch
09/01/2017 14:00
Jan 9 (Reuters) - Aequus Pharmaceuticals Inc AQS.V
* Aequus initiates second proof of concept clinical trial of
transdermal aripiprazole patch
Source text for Eikon: ID:nMKWGqCgka
Further company coverage: AQS.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Aequus Pharmaceuticals
See all newsBrief: Aequus Pharmaceutical Canada Pauses Sales Of Evolve Intensive Eyedrops, Gel In Canada
Brief: Aequus Announces Financing To Support Launch Of Zimed Preservative Free (Bimatoprost 0.03%) And Board Update
Brief: Aequus Announces Health Canada Notice Of Compliance For Zimed® Preservative Free
Brief: Aequus Announces Sandoz Contract Expiry At Year End And Expected Health Canada Approval For Zimed® Pf (Preservative Free)
Brief: Aequus Resumes Trading On TSX Venture Exchange